TABLE 4.
Top 10 most-cited articles on curcumin.
| Title | First author | Year | Number of citations | Journal | IF a | Publication type |
|---|---|---|---|---|---|---|
| Bioavailability of curcumin: Problems and promises | Anand P. | 2007 | 3364 | Molecular pharmaceutics | 4.939 | Review |
| Anticancer potential of curcumin: Preclinical and clinical studies | Aggarwal B.B. | 2003 | 2077 | Anticancer research | 2.48 | Review |
| Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo | Yang F. S. | 2005 | 1752 | Journal of biological chemistry | 5.157 | Article |
| Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions | Cheng A. L. | 2001 | 1653 | Anticancer research | 2.48 | Article |
| Curcumin as Curecumin: From kitchen to clinic | Goel A. | 2008 | 1523 | Biochemical pharmacology | 5.858 | Editorial material |
| Curcumin: From ancient medicine to current clinical trials | Hatcher H. | 2008 | 1312 | Cellular and molecular life sciences | 9.261 | Review |
| Multiple biological activities of curcumin: A short review | Maheshwari R. K. | 2006 | 1269 | Life sciences | 5.037 | Review |
| Curcumin: The story so far | Sharma R. A. | 2005 | 1225 | European journal of cancer | 9.162 | Review |
| Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases | Aggarwal B. B. | 2009 | 1216 | International journal of biochemistry and cell biology | 5.085 | Review |
| Stability of curcumin in buffer solutions and characterization of its degradation products | Wang Y. J. | 1997 | 1208 | Journal of pharmaceutical and biomedical analysis | 3.935 | Article |
a
IFs were from the journal citation report of 2020.